SCHEMBL8501004

SCHEMBL8501004

c1cc(-c2ccnc(-c3ccncc3)n2)ccn1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 5/20 0.70
GABRA1 P14867 1/20 0.60
GABRG2 P18507 1/20 0.60
GABRB3 P28472 1/20 0.60
GABRA5 P31644 1/20 0.60
GABRA3 P34903 1/20 0.60
KMT2A Q03164 9/20 0.54
MAPT P10636 7/20 0.54
CYP1A2 P05177 3/20 0.54
CYP3A4 P08684 3/20 0.54
CYP2D6 P10635 3/20 0.54
CYP2C9 P11712 3/20 0.54
CYP2C19 P33261 3/20 0.54
POLB P06746 2/20 0.54
THRB P10828 1/20 0.54
HTT P42858 1/20 0.54
NPSR1 Q6W5P4 1/20 0.54
MEN1 O00255 8/20 0.53
RAB9A P51151 2/20 0.53
ATM Q13315 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ammonia Solution, Strong SCHEMBL27968646 0.98 NPC1 (0.68) NPC1GABRA1GABRG2GABRB3GABRA5
SCHEMBL17694969 0.96 NPC1 (0.71) NPC1GABRA1GABRG2GABRB3GABRA5
SCHEMBL18905473 0.92 GABRA1 (0.71) NPC1GABRA1GABRG2GABRB3GABRA5
SCHEMBL7444977 0.88 KMT2A (0.72) NPC1GABRA1GABRG2GABRB3GABRA5
SCHEMBL22377088 0.88 GABRA1 (0.68) NPC1GABRA1GABRG2GABRB3GABRA5
SCHEMBL28145606 0.81 GABRA1 (0.64) NPC1GABRA1GABRG2GABRB3GABRA5
SCHEMBL190954 0.81 AURKA (0.63) NPC1GABRA1GABRG2GABRB3GABRA5
SCHEMBL29620532 0.81 AURKA (0.63) NPC1GABRA1GABRG2GABRB3GABRA5
SCHEMBL17343944 0.80 GABRA1 (0.55) NPC1GABRA1GABRG2GABRB3GABRA5
SCHEMBL17343967 0.80 GABRA1 (0.55) NPC1GABRA1GABRG2GABRB3GABRA5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103974948-B Substituted benzyl indazoles as BUB1 kinase inhibitors in the treatment of hyperproliferative diseases 拜耳医药股份有限公司 2017-07-28 CN claimed
CN-103974948-B Substituted benzyl indazoles as BUB1 kinase inhibitors in the treatment of hyperproliferative diseases 拜耳医药股份有限公司 2017-07-28 CN disclosed
EP-0948497-A2 SUBSTITUTED PYRIMIDINE COMPOUNDS AND THEIR USE Amgen inc. (US) 1999-10-13 EP disclosed
WO-1998024782-A2 SUBSTITUTED PYRIMIDINE COMPOUNDS AND THEIR USE AMGEN INC. (US) 1998-06-11 WO disclosed